“…5 sessions 78.8 | 0 | 6 | Erythema, pain, edema, low-grade fever | Diab et al 4 2021 (Egypt) | RCT | PPD | 20 | Simple, recalcitrant; common | - 0.01 mL PPD-5TU, intralesion on largest wart
- 2-weeks interval, max. 6 sessions
| 35 | 0 | 6 | Pain, myalgias, fever, erythema, edema, skin pigmentation |
Diab et al 28 2021 (Egypt) | RCT | - PPD (A)
- PPD + iso-tretinoin (B)
| A: 20 B: 20 | Simple, recalcitrant; common, plantar | - Group A: 0.1 mL PPD, intralesion on largest wart, 2-weeks interval, max. 6 sessions
- Group B: PPD as given in group A + low dose isotretinoin (0.2–0.4 mg/kg/day) for 3 months
| A: 35 B: 55 | A: 0 B: 9.1 | 3 | - All groups: erythema, edema, pain, dis-pigmentation, fever, myalgias
- B: cheilitis, dry skin
|
Durga-devi et al 29 2018 (India) | Open label study | - PPD (1)
- Topical 5% 5-fluorouracil (2)
| 1: 25 2: 25 | Simple, recalcitrant; peri-ungual, warts in other areas (not mentioned in detail) | - Group 1: PPD-1TU, volume injected determined by size of skin test reactivity according to Johnson et al 20 intralesion on one randomly selected lesion, 3-weeks interval, max.
|
…”